Investor Alert

Regeneron Pharmaceuticals Inc.

NAS: REGN

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 20, 2022, 6:54 p.m.

/zigman2/quotes/203149337/composite

$

662.89

Change

+1.75 +0.26%

Volume

Volume 40,395

Quotes are delayed by 20 min

/zigman2/quotes/203149337/composite

Previous close

$ 657.15

$ 661.14

Change

+3.99 +0.61%

Day low

Day high

$647.54

$664.90

Open

52 week low

52 week high

$492.13

$747.42

Open

Annual Financials for Regeneron Pharmaceuticals Inc.

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue 5.87B6.71B6.56B8.5B16.07B
Cost of Goods Sold (COGS) incl. D&A 542.53M582.3M975.4M1.36B2.72B
COGS excluding D&A 397.06M434.1M765.1M1.12B2.44B
Depreciation & Amortization Expense 145.47M148.2M210.3M235.9M286.2M
Depreciation 145.47M148.2M210.3M235.9M286.2M
Amortization of Intangibles -----
Gross Income 5.33B6.13B5.58B7.14B13.35B
20172018201920202021 5-year trend
SG&A Expense 3.25B3.59B3.58B3.85B4.45B
Research & Development 1.93B2.04B2.24B2.5B2.62B
Other SG&A 1.32B1.56B1.34B1.35B-
Other Operating Expense --(209.2M)(280.4M)(45.6M)
Unusual Expense 30.1M41.9M(118.3M)(196M)(386.1M)
EBIT after Unusual Expense 2.05B2.49B118.3M3.77B9.33B
Non Operating Income/Expense 54.14M89.2M131.2M94.7M50.2M
Non-Operating Interest Income -----
Equity in Affiliates (Pretax) -----
Interest Expense 25.12M28.2M30.2M56.9M57.3M
Gross Interest Expense 25.12M28.2M30.2M56.9M57.3M
Interest Capitalized -----
Pretax Income 2.08B2.55B2.43B3.81B9.33B
Income Tax 880M109.1M313.3M297.2M1.25B
Income Tax - Current Domestic 556.16M228.5M446.5M200.2M1.44B
Income Tax - Current Foreign 4.83M20.6M(2.6M)21.4M(38.4M)
Income Tax - Deferred Domestic 315.81M685.7M(133.7M)107M(423.8M)
Income Tax - Deferred Foreign 3.2M(825.7M)3.1M(31.4M)276.7M
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income 1.2B2.44B2.12B3.51B8.08B
Minority Interest Expense -----
Net Income 1.2B2.44B2.12B3.51B8.08B
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries 1.2B2.44B2.12B3.51B8.08B
Preferred Dividends -----
Net Income Available to Common 1.2B2.44B2.12B3.51B8.08B
EPS (Basic) 11.2722.6519.3832.6576.40
Basic Shares Outstanding 106.34M107.9M109.2M107.6M105.7M
EPS (Diluted) 10.3421.2918.4630.5271.97
Diluted Shares Outstanding 115.95M114.8M114.6M115.1M112.2M
EBITDA 2.23B2.68B2.42B3.81B9.23B
Link to MarketWatch's Slice.